New in Drug Safety

Another Alzheimer’s drug candidate suffers setback

17 June 2013 / By Tim / Clinical Trials, Drug Safety, Featured on app / 0 comments

It’s not been a good couple of years for Alzheimer’s research. Recently, Baxter’s Gammagard joined J&J and Pfizer’s iv bapineuzumab and Eli Lilly’s solanezumab in [...]

 

More in Drug Safety

• 

  Download: eBook ‘Best practice strategies for drug safety in Asia’

  13 June 2013 / By Kerry / Drug Safety / 1 comment

   
• 

  Download: Presentation ‘Assessing the effectiveness of Risk Management Plans’

  10 June 2013 / By Kerry / Drug Safety / 1 comment

   
• 

  GLP-1 diabetes drugs and pancreatic damage – has it been underplayed? BMJ, Channel 4 investigate

  10 June 2013 / By Tim / Drug Safety, Featured on app / 0 comments

   
• 

  GSK’s Avandia: FDA panel recommend rosiglitazone restriction relaxation

  7 June 2013 / By Tim / Drug Safety, Featured on app / 0 comments

   
• 

  Guest Post: Using the cognitive sciences to improve patient reported outcome (PRO) measurement

  4 June 2013 / By Tim / Drug Safety, Featured on app / 0 comments

   
• 

  Risk-based monitoring could significantly modernize and streamline clinical trials

  4 June 2013 / By Tim / Drug Safety, Featured on app / 0 comments

   
• 

  Download Press Release: Shire to Acquire SARcode Bioscience, Expands Presence in Ohthalmology

  31 May 2013 / By jolene / Drug Discovery, Drug Safety, Market Access, Orphan Drugs / 0 comments

   
• 

  Guest Blog: Patient Reported Outcomes – The challenges still facing us

  30 May 2013 / By Tim / Drug Safety, Featured on app / 0 comments

   
• 

  Download: eBook ‘Key stakeholders insights into benefit risk communication’

  24 May 2013 / By Kerry / Drug Safety / 0 comments

   
• 

  FDA panel backs Merck insomnia drug, but warns of safety concerns

  24 May 2013 / By Tim / Drug Safety, Featured on app / 0 comments